Hawkes, Eliza <br/><br/>
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  May 2011 
 - 1146-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2010.12.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Camptothecin--administration & dosage<br/>Cohort Studies<br/>Disease Progression<br/>Docetaxel<br/>Esophageal Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Retrospective Studies<br/>Stomach Neoplasms--drug therapy<br/>Taxoids--administration & dosage<br/>Treatment Outcome